Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Targeting CYP51A1: small-Molecule inhibitors and therapeutic potential The cholesterol biosynthetic pathway has proven to be a successful target in drug development, as exemplified by statins for hypercholesterolemia and azole antifungals for infectious diseases [97, 98]
Bristol Myers Squibbs Eliquis, generating over $13 billion in 2024 revenue, with key patents expiring 2026-2028
One amino acid that has garnered substantial attention as an anticancer target is cysteine 8,9
Regulatory approvals have focused on weight loss efficacy as the primary endpoint with cardiovascular benefits considered secondary outcomes
For example, in response to the surging demand for tirzepatide (the active ingredient in its GLP-1 injections), Lilly built a manufacturing facility in Ireland capable of producing five metric tons of the drug per year
Psychiatry 21 , 797805 (2016)
US$ 26.72
US$ 29.65
US$ 20.57
US$ 28.76
US$ 28.29
